Association Between Immune-Related Adverse Events and Recurrence-Free Survival Among Patients With Stage III Melanoma Randomized to Receive Pembrolizumab or Placebo
N
Shared by NobleBlocks on Apr 1, 2020 • 12:00 AM UTC
Authors:
Alexander M. M. Eggermont
,
Michal Kicinski
,
Christian U. Blank
Research Assistant
AI chat, annotations, notes & similar papers
Finding related papers...
Discussions
(0)
No comments yet
Be the first to share your thoughts!
Association Between Immune-Related Adverse Events and Recurrence-Free Survival Among Patients With Stage III Melanoma Randomized to Receive Pembrolizumab or Placebo | NobleBlocks
